C4 Therapeutics, Inc. (NASDAQ:CCCC) Given Average Rating of "Hold" by Brokerages
C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Free Report) has been given a consensus recommendation of “Hold” by the seven research firms that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, three have given a hold recommendation and two have issued a buy recommendation on the […]